Literature DB >> 1458798

Rheumatoid arthritis, corticosteroid therapy and Kaposi's sarcoma: a coincidence? A case and review of literature.

P Casoli1, B Tumiati.   

Abstract

We describe a 68-year-old woman suffering from rheumatoid arthritis treated with low doses of prednisone who developed Kaposi's sarcoma (KS). This patient was not affected with AIDS, and two years previously, her sister had also complained of KS. In the literature only 8 rheumatoid arthritis patients who developed KS during steroid therapy have been reported. We present a review of the literature and question the responsibility of corticosteroids and autoimmune diseases as the cause of KS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1458798     DOI: 10.1007/bf02207213

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  Kaposi Sarcoma complicating systemic lupus erythematosus treated with immunosuppression.

Authors:  M B Klein; F A Pereira; I Kantor
Journal:  Arch Dermatol       Date:  1974-10

2.  Kaposi's sarcoma and immunosuppressive therapy: an appraisal.

Authors:  R W Gange; E W Jones
Journal:  Clin Exp Dermatol       Date:  1978-06       Impact factor: 3.470

3.  Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implications.

Authors:  B Safai; V Miké; G Giraldo; E Beth; R A Good
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

4.  [Association of rheumatoid arthritis and Kaposi's disease. Apropos of a case].

Authors:  A M Piette; A Prier; J P Camus; M C di Crescenzo
Journal:  Rev Rhum Mal Osteoartic       Date:  1981-11

5.  Association of Kaposi's sarcoma and prior immunosuppressive therapy: a 5-year material of Kaposi's sarcoma in Norway.

Authors:  O Klepp; O Dahl; J T Stenwig
Journal:  Cancer       Date:  1978-12       Impact factor: 6.860

6.  Kaposi's sarcoma in a patient with SLE.

Authors:  D I Greenfield; P Trinh; A Fulenwider; W F Barth
Journal:  J Rheumatol       Date:  1986-06       Impact factor: 4.666

7.  Familial Kaposi's sarcoma.

Authors:  A Y Finlay; R Marks
Journal:  Br J Dermatol       Date:  1979-03       Impact factor: 9.302

8.  Kaposi's sarcoma. IV. Detection of CMV DNA, CMV RNA and CMNA in tumor biopsies.

Authors:  I Boldogh; E Beth; E S Huang; S K Kyalwazi; G Giraldo
Journal:  Int J Cancer       Date:  1981-10-15       Impact factor: 7.396

9.  Kaposi's sarcoma. Retrospective study of 90 cases with particular emphasis on the familial occurrence, ethnic background and prevalence of other diseases.

Authors:  J J DiGiovanna; B Safai
Journal:  Am J Med       Date:  1981-11       Impact factor: 4.965

10.  Kaposi's sarcoma complicating corticosteroid therapy for temporal arteritis.

Authors:  F Leung; A G Fam; D Osoba
Journal:  Am J Med       Date:  1981-08       Impact factor: 4.965

View more
  4 in total

1.  Kaposi sarcoma after corticosteroid therapy for idiopathic thrombocytopenic purpura.

Authors:  Kwang Hyun Choi; Jae Ho Byun; Jun Young Lee; Baik Kee Cho; Hyun Jeong Park
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

Review 2.  Tumor necrosis factor blockade and the risk of viral infection.

Authors:  Seo Young Kim; Daniel H Solomon
Journal:  Nat Rev Rheumatol       Date:  2010-02-09       Impact factor: 20.543

Review 3.  Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review.

Authors:  Benedict K Tiong; Arun S Singh; G Peter Sarantopoulos; Tanaz A Kermani
Journal:  Rheumatol Int       Date:  2021-02-23       Impact factor: 2.631

4.  Disseminated cutaneous and visceral Kaposi sarcoma in a woman with rheumatoid arthritis receiving leflunomide.

Authors:  Sang Yeob Lee; Yong Min Jo; Won Tae Chung; Sung Hyun Kim; Seung Young Kim; Mee Sook Roh; Sung Won Lee
Journal:  Rheumatol Int       Date:  2010-01-10       Impact factor: 3.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.